Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL509780 | 0.81 | ALDH1A1 (0.43) | ALDH1A1 | |
| SCHEMBL942008 | 0.77 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL238158 | 0.76 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL5968591 | 0.74 | EGLN1 (0.39) | ALDH1A1 | |
| SCHEMBL5785545 | 0.74 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL731664 | 0.74 | ALDH1A1 (0.46) | ALDH1A1 | |
| SCHEMBL705151 | 0.74 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL1768486 | 0.72 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL781568 | 0.72 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL733088 | 0.72 | ALDH1A1 (0.62) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 586 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250381259-A1 | Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof | PFIZER (US) | 2025-12-18 | — | — | US | claimed |
| EP-4661911-A1 | IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF | Pfizer Inc. (US) | 2025-12-17 | — | — | EP | claimed |
| WO-2025133971-A1 | IMPROVED METHODS FOR PRODUCING BACTERIAL CAPSULAR SACCHARIDE GLYCOCONJUGATES | PFIZER INC. (US) | 2025-06-26 | — | — | WO | claimed |
| CN-119978237-A | Responsive elastomeric polymers and methods of making and using the same | 珀杜研究基金会 | 2025-05-13 | — | — | CN | claimed |
| EP-4463186-A1 | IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF | Pfizer Inc. (US) | 2024-11-20 | — | — | EP | claimed |
| CN-118510548-A | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | 辉瑞公司 | 2024-08-16 | — | — | CN | claimed |
| US-20240271085-A1 | ACTIVATED DISSOLVABLE SUPPORTS FOR AFFINITY BINDING AND CELL CULTURE | CORNING INCORPORATED | 2024-08-15 | — | — | US | claimed |
| WO-2024166008-A1 | IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF | PFIZER INC. (US) | 2024-08-15 | — | — | WO | claimed |
| EP-4346892-A2 | IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF | Pfizer Inc. (US) | 2024-04-10 | — | — | EP | claimed |
| CN-117729933-A | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | 辉瑞公司 | 2024-03-19 | — | — | CN | claimed |
| EP-2078197-B1 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | VENTANA MED SYST INC (US) | 2016-03-23 | — | — | EP | claimed |
| US-20140161877-A1 | PEDERIN AND PSYMBERIN AGENTS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2014-06-12 | — | — | US | claimed |
| EP-2444807-B1 | MONO- AND DINITROPYRAZOLE HAPTEN CONJUGATES | VENTANA MED SYST INC (US) | 2014-06-11 | — | — | EP | claimed |
| US-20130005660-A1 | Plasma Activation of Biological Materials for Surface Modification | ORTHOBOND, INC. (US) | 2013-01-03 | — | — | US | claimed |
| US-20120294953-A1 | Surface Modified Biological Materials | ORTHOBOND, INC. (US) | 2012-11-22 | — | — | US | claimed |
| WO-2012149330-A1 | SURFACE MODIFIED BIOLOGICAL MATERIALS | ORTHOBOND, INC. (US) | 2012-11-01 | — | — | WO | claimed |
| WO-2012149366-A1 | PLASMA ACTIVATION OF BIOLOGICAL MATERIALS FOR SURFACE MODIFICATION | ORTHOBOND, INC. (US) | 2012-11-01 | — | — | WO | claimed |
| EP-2444807-A2 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | Ventana Medical Systems, Inc. (US) | 2012-04-25 | — | — | EP | claimed |
| EP-2275085-A1 | Biodegradable copolymer suitable for delivering nucleic acid materials into cells | University of Rostock (DE) | 2011-01-19 | — | — | EP | claimed |
| US-20040185564-A1 | Biodegradable copolymers containing polyethylenimine that are capable of complexing with nucleic acid and serving as tools for gene transfer; gene therapy | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2004-09-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140161877-A1 | PEDERIN AND PSYMBERIN AGENTS | PRSS12, CCL2, APLNR | ALDH1A1 3928/4885 |
| US-20250381259-A1 | Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof | CD44, CD47, FUT5 | ALDH1A1 3290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.